期刊文献+

雷公藤多甙在维持术后克罗恩病临床缓解中的作用 被引量:6

Maintenance effect of polyglycosides of Tripterygium wilfordii on remission in postoperative Crohn disease
原文传递
导出
摘要 目的 观察雷公藤多甙对克罗恩病术后患者的维持临床缓解作用。方法将2005年至2007年间收治的克罗恩病术后患者45例随机分为2组,分别接受雷公藤多甙和美沙拉嗪治疗;术后3个月、半年和1年或出现临床症状时进行疾病活动度指数(CDAI)评价,并在术后1年或复发时行肠镜检查和行Rutgeert术后内镜复发评分。结果雷公藤多甙组与美沙拉嗪组比较,3个月内两组均无复发.半年内累计复发率分别为18.2%与21.7%(P=0.530);1年内累计复发率分别为31.8%与39.1%(P=0.421),差异均无统计学意义;1年内内镜下累计复发率分别为45.5%和60.9%(P=0.231).差异也无统计学意义。结论雷公藤多甙对维持术后克罗恩病缓解的作用与美沙拉嗪相似。 Objective To observe the maintenance effect of polyglycosides of Tripterygium wilfordii (GTW) on remission in postoperative Crohn disease(CD). Methods From 2005 to 2007, 45 adult cases of postoperative Crohn disease were randomly divided into two groups, GTW group and mesalazine group, which received GTW and mesalazine treatment respectively. CD activity index(CDAI) and clinical markers were collected at 0, 3, 6, 12 months or at the onset of symptoms, lleocolonoscopy was performed at the end of the trial( 1 year after operation) or at the onset of symptoms, and recurrence score were recorded. Results No clinical recurrence was ascertained in both groups at 3 months. Four patients (18.2%) in GTW group relapsed and 5 (21.7%) in mesalazine group relapsed at 6 months (P= 0.530). Seven patients(31.8%) in GTW group and 9(39.1%) in mesalazine group relapsed at one year (P=0.421). Ten patients (45.5%) in GTW group had endoscopic recurrence compared with 14 (60.9%) in mesalazine group at one year(P=0.231). There were no significant differences between two groups. Conclusion GTW is similar to mesalazine in maintenance of remission of postoperative Crohn disease.
出处 《中华胃肠外科杂志》 CAS 北大核心 2009年第5期491-493,共3页 Chinese Journal of Gastrointestinal Surgery
基金 基金项目:东南大学913事业科研基金资助(9290002452)
关键词 克罗恩病 雷公藤 复发 Crohn disease Tripterygium wilfordii Recurrence
  • 相关文献

参考文献4

二级参考文献42

  • 1汪建平,兰平,周军.克罗恩病的围手术期处理[J].中国实用外科杂志,2004,24(7):444-445. 被引量:3
  • 2Lichtenstein GR. Treatment of fistulizing Crohn's disease. Gastroenterology,2000,119,1132-1147.
  • 3Bataille F,Klebl F,Rummele P,et al. Morphological characterization of Crohn's disease fistulae. Gut,2004,53: 1314-1321.
  • 4Krok KL,Lichtenstein GR. Nutrition in Crohn disease. Curr Opin Gastroenterol,2003,19:148-153.
  • 5Carter M J, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 Suppl 5:V1-16.
  • 6Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, WestAB Ⅱ. Intestinal subepithelial myofibroblasts. Am J Physiol1999; 277(2 Pt 1): C183-201.
  • 7McKaig BC, McWilliams D, Watson SA, Mahida YR. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease. Am J Pathol 2003; 162: 1355-60.
  • 8Kruidenier L, Macdonald TT, Collins JE, Pender SLF, Sanderson IR. Myofibroblast matrix metalloproteinases activate the neutrophil chemoattractant CXCL7 from intestinal epithelial cells.Gastroenterology 2006; 130:127-36
  • 9Salmela MT, MacDonald TT, Black D, Irvine B, Zhuma T,Saarialho-Kere U, et al. Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut:analysis by gene array and in situ hybridization. Gut 2002; 51:540-7.
  • 10Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003; 199: 28-35.

共引文献33

同被引文献89

引证文献6

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部